Document is current
Any future updates will be listed below
-
Authors
Bastl, Katharina https://orcid.org/0000-0002-8200-9708
Bastl, Maximilian https://orcid.org/0000-0002-2182-0409
Morgenstern, Christina https://orcid.org/0000-0003-2943-9634
Eckl-Dorna, Julia https://orcid.org/0000-0001-5981-1607
Schepelmann, Martin https://orcid.org/0000-0002-7017-5426
-
Funding
Funding for this research was provided by:
Austrian Science Fund (P 32840-B)
Herzfelder'sche Familienstiftung
Medical University of Vienna
- License Information
-
More Information
Article History
Received: 3 May 2024
Accepted: 14 August 2024
First Online: 19 September 2024
Declarations
:
: J.E.-D. served as a speaker and/or consultant and/or advisory board member for Sanofi, Allergopharma, AstraZeneca, GSK, and Novartis. She is an investigator for Novartis and AstraZeneca (grants paid to her institution). All other authors report no competing interests.
: Not applicable.
